<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source></source><date>Sat Feb 27 04:03:17 EST 2016</date><key></key>
<document><id>20533546</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Our findings indicate that canakinumab 150 mg provides rapid and sustained pain relief in patients with acute gouty arthritis, and significantly reduces the risk of recurrent flares compared with triamcinolone acetonide.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="39" length="11"/><text>canakinumab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="208" length="13"/><text>triamcinolone</text></annotation></passage></document>
<document><id>19799584</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The plasma lipid peroxidation was determined and reported as thiobarbituric acid reactive substance and was significantly increased (+21%), whereas the activities of the erythrocyte antioxidant enzymes glutathione peroxidase, catalase, and superoxide dismutase were significantly decreased (-32%, -14% and -31%, respectively) in amphetamine users.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="202" length="22"/><text>glutathione peroxidase</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="329" length="11"/><text>amphetamine</text></annotation></passage></document>
<document><id>22086230</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Millions of individuals are prescribed platelet inhibitors, such as aspirin and clopidogrel, to reduce their risk of thrombosis-related clinical events.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="68" length="7"/><text>aspirin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="80" length="11"/><text>clopidogrel</text></annotation></passage></document>
<document><id>21167958</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The cyclooxygenase inhibitor indomethacin normalized this response, and the concentration of the stable metabolite of prostacyclin in the aorta of CLP rats increased in basal conditions and after stimulation with acetylcholine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="29" length="12"/><text>indomethacin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="213" length="13"/><text>acetylcholine</text></annotation></passage></document>
<document><id>23109506</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Plasma calcium did not change, but concentrations of insulin (P?&lt;?0.01) and zinc (P?&lt;?0.01) were greater, while that of copper was lower (P?&lt;?0.01) in the plasma of treated cows.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="7" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="76" length="4"/><text>zinc</text></annotation></passage></document>
<document><id>21029513</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The Nicotrol® (Pfizer, USA) nicotine inhaler reduces craving by mimicking the behavioural component of cigarettes and delivering controlled doses of nicotine, which binds to the beta-2 subunit-containing nicotinic acetylcholine receptors (ß2*-nAChRs).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="149" length="8"/><text>nicotine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="214" length="13"/><text>acetylcholine</text></annotation></passage></document>
<document><id>20379653</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The breast cancer cell line MCF7 and the lung cancer cell line H1299 were treated with usnic acid 29 microM for 24 hours and two positive controls: vincristine (which prevents the formation of microtubules) or taxol (which stabilizes microtubules).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="148" length="11"/><text>vincristine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="210" length="5"/><text>taxol</text></annotation></passage></document>
<document><id>20616903</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Recently it has been demonstrated that mutations in KRAS predict the efficacy of panitumumab and cetuximab, limiting their use to CRC patients with wild-type KRAS, and moving the clinical field towards personalized cancer care.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="81" length="11"/><text>panitumumab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="97" length="9"/><text>cetuximab</text></annotation></passage></document>
<document><id>19926736</id><passage><infon key="DDI">No</infon><offset>0</offset><text>These results indicate a major role of acetylcholine in airway inflammation and remodelling in a GORD model, and demonstrate that tiotropium and atropine can prevent lung inflammation with an effectiveness similar to intraperitoneal dexamethasone, providing additional evidence that anticholinergics might contribute to the control of inflammatory processes in airway diseases.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="145" length="8"/><text>atropine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="233" length="13"/><text>dexamethasone</text></annotation></passage></document>
<document><id>21192248</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Tolvaptan (TOL; selective V2 antagonist) and Conivaptan (CON; dual V1a/V2 antagonist) are two AVP antagonists that counteract the action of AVP with distinct profiles.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="9"/><text>tolvaptan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="45" length="10"/><text>conivaptan</text></annotation></passage></document>
<document><id>21324252</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: The findings suggest that lowering sodium intake while maintaining high levels of dietary calcium and magnesium may help prevent ischemic stroke in southern Chinese adults.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="102" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="114" length="9"/><text>magnesium</text></annotation></passage></document>
<document><id>23361602</id><passage><infon key="DDI">No</infon><offset>0</offset><text>On the other hand, dihydropyridine calcium channel blockers, such as amlodipine, have been proven to lower the incidence of stroke but their use seems to be effective in relieving symptoms of coronary artery disease and reducing the rate of revascularisation procedures.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="35" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="69" length="10"/><text>amlodipine</text></annotation></passage></document>
<document><id>20417943</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Our studies further support the notion that 1-phenylpropane-1,2-dione and (S)-cathinone are biosynthetic precursors of the ephedrine alkaloids in E. sinica stems and that the activity of (S)-cathinone reductases directs and determines the stereochemical branching of the pathway.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="123" length="9"/><text>ephedrine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="191" length="9"/><text>cathinone</text></annotation></passage></document>
<document><id>21777884</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: In patients with diabetes mellitus presenting with STEMI undergoing primary PCI, anticoagulant therapy with bivalirudin compared with heparin plus GPI is safe and effective and might reduce cardiac mortality at 30 days and 1 year.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="121" length="11"/><text>bivalirudin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="147" length="7"/><text>heparin</text></annotation></passage></document>
<document><id>22282267</id><passage><infon key="DDI">No</infon><offset>0</offset><text>As both the response to prednisolone in vitro and prednisone in vivo are predictive for clinical outcome, understanding and overcoming glucocorticoid resistance remains an essential step towards improving prognosis.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="24" length="12"/><text>prednisolone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="50" length="10"/><text>prednisone</text></annotation></passage></document>
<document><id>19867626</id><passage><infon key="DDI">No</infon><offset>0</offset><text>During the period of retention the chlorine content of the blood is distinctly lower than normally, the calcium content is apparently slightly lower, and the magnesium content tends also to be a little lower.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="104" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="158" length="9"/><text>magnesium</text></annotation></passage></document>
<document><id>21249693</id><passage><infon key="DDI">No</infon><offset>0</offset><text>AUTHORS&amp;apos; CONCLUSIONS: Sublingual nitroglycerin, given when oxytocin fails, seems to reduce both the need for manual removal of placenta and blood loss during the third stage of labour when compared to placebo.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="38" length="13"/><text>nitroglycerin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="64" length="8"/><text>oxytocin</text></annotation></passage></document>
<document><id>20375835</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Recent initiatives using lower doses of capecitabine and irinotecan, as well as alternative dosing schedules, have resulted in more favorable outcomes (efficacy and tolerability), even in combination with targeted-agents such as bevacizumab.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="57" length="10"/><text>irinotecan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="229" length="11"/><text>bevacizumab</text></annotation></passage></document>
<document><id>22301767</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: These data do not support the use of NMDA receptor antagonists, ketamine and magnesium sulfate to prevent the development of remifentanil-induced postoperative hyperalgesia and tolerance.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="89" length="9"/><text>magnesium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="137" length="12"/><text>remifentanil</text></annotation></passage></document>
<document><id>20682803</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Ribavirin and 6-aza-uridine were able to delay but not prevent NiV-induced mortality in hamsters.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="9"/><text>ribavirin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="20" length="7"/><text>uridine</text></annotation></passage></document>
<document><id>19117833</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Administration of oral cholecalciferol to HIV-infected children and adolescents at a dosage of 100,000 IU every 2 months, together with 1 g/day calcium, is safe and results in significant increases in serum 25-hydroxyvitamin D concentrations.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="36" length="15"/><text>cholecalciferol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="157" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>19695244</id><passage><infon key="DDI">No</infon><offset>0</offset><text>However, at 0.63 mg/kg, F15063 induced a lower degree of striatal IEG mRNA expression than haloperidol and pretreatment with the serotonin 5-HT(1A) receptor antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-(2-pyridinyl)cyclohexane carboxamide trihydrochloride (WAY100635) (0.63 mg/kg) increased the level of IEG mRNA induction by F15063.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="91" length="11"/><text>haloperidol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="229" length="11"/><text>cyclohexane</text></annotation></passage></document>
<document><id>23251458</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Pretreatment of rats with hexamethonium (20 mg/kg/day) to antagonize peripheral nicotinic receptors except for a7 nicotinic acetylcholine receptor (a7-nAChR) had no effect on the insulin sensitizing effect of nicotine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="124" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="209" length="8"/><text>nicotine</text></annotation></passage></document>
<document><id>23385037</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Both atropine and labetalol were able to lower the frequency of bradycardia.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="17" length="8"/><text>atropine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="30" length="9"/><text>labetalol</text></annotation></passage></document>
<document><id>20922425</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The results indicate that under the same dose level of mefloquine, the efficacy of single dose is superior to that of multiple daily doses; mefloquine combined with artesunate or artemether at an invalid or moderate effective dose may show synergistic effect, especially the effect against female worms; no prominent synergistic effect is observed, when the similar dose level of mefloquine in combination with praziquantel.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="380" length="10"/><text>mefloquine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="411" length="12"/><text>praziquantel</text></annotation></passage></document>
<document><id>20689584</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Some clinically important exceptions, however, were apparent: women experienced substantially lower response rates with newer antiemetics than men (45% vs. 58%; relative risk 1.49, 95% confidence interval 1.35-1.64); men had higher rates of sexual dysfunction than women while on paroxetine for major depressive disorder; women discontinued lovastatin more frequently than men because of adverse events.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="280" length="10"/><text>paroxetine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="341" length="10"/><text>lovastatin</text></annotation></passage></document>
<document><id>19234324</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The pharmacokinetics and pharmacodynamics of porcine insulin zinc suspension were studied in eight dogs with spontaneous diabetes mellitus and a lack of endogenous insulin, demonstrated by the lack of insulin secretion after an injection of glucagon and confirmed by measurement of the concentration of C-peptide during the pharmacokinetic assessments.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="45" length="20"/><text>porcine insulin zinc</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="241" length="8"/><text>glucagon</text></annotation></passage></document>
<document><id>20513938</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Secondly, the efficacy of targeted therapy drugs such as Cetuximab and Erlotinib, or non- targeted agents such as temozolomide and nitrosourea has been influenced by the presence of certain genetic or epigenetic markers in tumors.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="71" length="9"/><text>erlotinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="114" length="12"/><text>temozolomide</text></annotation></passage></document>
<document><id>22372517</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Mucosal injury with diclofenac-K liquid 25 mg liquid capsules was similar to diclofenac-K 25 mg tablets, significantly lower than ASA 1 g tablets and showed some superiority over ibuprofen 400 mg liquid capsules (EudraCT Number 2009-011278-14).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="90" length="10"/><text>diclofenac</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="192" length="9"/><text>ibuprofen</text></annotation></passage></document>
<document><id>21303920</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The cysteine prodrug N-acetylcysteine (NAC) has been shown to reduce reinstatement of cocaine seeking by normalization of glutamatergic tone.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="23" length="14"/><text>acetylcysteine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="86" length="7"/><text>cocaine</text></annotation></passage></document>
<document><id>19928832</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Isoflavones such as genistein (10), biochanin A (11), tectorigenin (12), and 2&amp;apos;-methoxyformononetin (13) stimulated the proliferation of both cells, and concentrations of lower than 1 muM of these compounds showed equivalent activity to 10 pM of estradiol (E2).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="20" length="9"/><text>genistein</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="251" length="9"/><text>estradiol</text></annotation></passage></document>
<document><id>21812506</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Canakinumab, a fully human anti-IL-1ß monoclonal antibody, has been shown to produce rapid and sustained pain relief from acute flares in patients with difficult-to-treat disease, and both rilonacept and canakinumab have been shown to reduce the risk of recurrent flares.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="189" length="10"/><text>rilonacept</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="204" length="11"/><text>canakinumab</text></annotation></passage></document>
<document><id>23009186</id><passage><infon key="DDI">No</infon><offset>0</offset><text>However, the authors were unable to reduce KAV using adjunctive atropine or metoclopramide.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="64" length="8"/><text>atropine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="76" length="14"/><text>metoclopramide</text></annotation></passage></document>
<document><id>21494026</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: In order to prevent rebound or relapse, various approaches are available, including cyclosporine, methotrexate and biologic therapies.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="96" length="12"/><text>cyclosporine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="110" length="12"/><text>methotrexate</text></annotation></passage></document>
<document><id>22826137</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: As compared to norepinephrine-induced hypertension, dobutamine-induced high CI did not reduce the rate of vasospasm in SAH patients.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="27" length="14"/><text>norepinephrine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="64" length="10"/><text>dobutamine</text></annotation></passage></document>
<document><id>21566104</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Rituximab and lower doses of prednisone and calcineurin inhibitors are noninferior to standard therapy in maintaining short-term remission in children with INS dependent on both drugs and allow their temporary withdrawal.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="13" length="9"/><text>rituximab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="42" length="10"/><text>prednisone</text></annotation></passage></document>
<document><id>23100433</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Importantly, we report that inhibition of AMPARs in the DMS attenuates operant self-administration of ethanol, but not of sucrose.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="102" length="7"/><text>ethanol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="122" length="7"/><text>sucrose</text></annotation></passage></document>
<document><id>21623147</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In one 36-month trial of teriparatide vs alendronate for GIOP in men and women, the anabolic agent led to a greater increase in bone density and was associated with a lower incidence of morphologic vertebral fractures.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="25" length="12"/><text>teriparatide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="41" length="11"/><text>alendronate</text></annotation></passage></document>
<document><id>20971799</id><passage><infon key="DDI">No</infon><offset>0</offset><text>It further showed that melatonin together with insulin synergistically enhanced the leptin synthesis by adipose tissue through phosphorylation of mitogen-activated protein kinase in C. sphinx.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="23" length="9"/><text>melatonin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="84" length="6"/><text>leptin</text></annotation></passage></document>
<document><id>20102369</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Analogues with 9-deazaguanine aglycone have better anti-leukaemic and anti-lymphoma activities compared to the guanine and hypoxanthine analogues, and applied in the concentration of 100 mum, caused a statistically significant decrease in the cell viability in all human leukaemia and lymphoma cells used.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="111" length="7"/><text>guanine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="123" length="12"/><text>hypoxanthine</text></annotation></passage></document>
<document><id>20383847</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Naphazoline/antazoline had lower tolerability than the other study treatments.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="11"/><text>naphazoline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="12" length="10"/><text>antazoline</text></annotation></passage></document>
<document><id>20827420</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Dexmedetomidine infusion without a bolus appears to be an effective adjunct to fentanyl anesthesia in control of hemodynamic responses to surgery for repair of CHD in children.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="15"/><text>dexmedetomidine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="79" length="8"/><text>fentanyl</text></annotation></passage></document>
<document><id>19952958</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In this report, we demonstrate that monomeric rituximab, at the high concentrations found in plasma following infusion of therapeutic doses, induces prolonged low-amplitude release of calcium from thapsigargin-sensitive intracellular stores and reduces the growth of Ramos B cells in culture.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="46" length="9"/><text>rituximab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="184" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>22802617</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We found that the antihypertensive drug Prazosin inhibits endocytic sorting by an off-target perturbation of the G protein-coupled receptor dopamine receptor D(3) (DRD3).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="40" length="8"/><text>prazosin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="140" length="8"/><text>dopamine</text></annotation></passage></document>
<document><id>21899046</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The influence of angiostatin K1-4.5--a fragment of the heavy chain of plasmin and a powerful inhibitor of angiogenesis--on kinetic parameters (k(Pg) and K(Pg)) of human Glu-plasminogen activation under the action of urokinase (uPA) not having affinity for fibrin and fibrin-specific tissue plasminogen activator (tPA) was investigated.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="290" length="7"/><text>plasmin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="216" length="9"/><text>urokinase</text></annotation></passage></document>
<document><id>20956588</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Thus, the administration of tenofovir-emtricitabine for at least 3 weeks after delivery should be considered to prevent the emergence of resistant viruses.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="28" length="9"/><text>tenofovir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="38" length="13"/><text>emtricitabine</text></annotation></passage></document>
<document><id>21121499</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The purpose of this study was to evaluate the effect of atropine dose, pyridostigmine bromide (PB) pretreatment, and oxime selection on the efficacy of SCP as an adjunctive treatment to enhance survival following lethal nerve agent exposure in guinea pigs.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="56" length="8"/><text>atropine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="71" length="14"/><text>pyridostigmine</text></annotation></passage></document>
<document><id>21528189</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Similarly to paclitaxel (Taxol), epothilone A inhibits cell proliferation and induces apoptosis by binding to tubulin and stabilizing of microtubuli.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="13" length="10"/><text>paclitaxel</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="25" length="5"/><text>taxol</text></annotation></passage></document>
<document><id>19337434</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The optimal ritonavir dose to be given together with fosamprenavir is still to be defined, though available results indicate that a dose of 100 mg may be adequate provided that no protease inhibitor resistance is present.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="12" length="9"/><text>ritonavir</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="53" length="13"/><text>fosamprenavir</text></annotation></passage></document>
<document><id>21163770</id><passage><infon key="DDI">No</infon><offset>0</offset><text>As a result of molecularly targeted anti-EGFR therapies (cetuximab and panitumumab) complementing chemotherapy, liver metastases can reduce in size and become operable in certain patients, which can contribute to the complete recovery of the patient.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="57" length="9"/><text>cetuximab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="71" length="11"/><text>panitumumab</text></annotation></passage></document>
<document><id>22436281</id><passage><infon key="DDI">No</infon><offset>0</offset><text>This was concomitant with a decrease (P &lt; 0.05) in the activity of enzymes involved in de novo fatty acid (FA) synthesis (FA synthase and glucose-6-phosphate dehydrogenase) and FA esterification (glycerol-3-phosphate dehydrogenase) when expressed per million adipocytes, and with an increase (P ? 0.01) in mRNA abundances for uncoupling protein 1, adiponectin and leptin (LEP) between 180 and 260 dpc.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="196" length="8"/><text>glycerol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="364" length="6"/><text>leptin</text></annotation></passage></document>
<document><id>21226576</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Among children 6 to 23 months of age with acute otitis media, treatment with amoxicillin-clavulanate for 10 days tended to reduce the time to resolution of symptoms and reduced the overall symptom burden and the rate of persistent signs of acute infection on otoscopic examination.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="90" length="11"/><text>amoxicillin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="102" length="11"/><text>clavulanate</text></annotation></passage></document>
<document><id>19536523</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Interestingly, the action of amiodarone is additive with the one of chloroquine, a known inhibitor of ABC-transporters.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="29" length="10"/><text>amiodarone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="68" length="11"/><text>chloroquine</text></annotation></passage></document>
<document><id>23357947</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The examination demonstrated that 1% acetic acid/95% ethanol fixative together with zinc staining provided a high contrast micro-CT image, enabling the segmentation of soft tissues.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="53" length="7"/><text>ethanol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="84" length="4"/><text>zinc</text></annotation></passage></document>
<document><id>21119328</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Toxicological examination confirmed a recent intake of mefloquine together with chloroquine, another antimalarial drug.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="55" length="10"/><text>mefloquine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="80" length="11"/><text>chloroquine</text></annotation></passage></document>
<document><id>22899742</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In contrast, the chromogenic antifactor Xa assay proved to be sensitive to lower amounts of rivaroxaban and apixaban with less variability.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="92" length="11"/><text>rivaroxaban</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="108" length="8"/><text>apixaban</text></annotation></passage></document>
<document><id>23187781</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Tiagabine (Gabitril) is an anticonvulsive drug that binds selectively to GABA transporter-1 and thereby inhibits GABA uptake.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="9"/><text>tiagabine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="11" length="8"/><text>gabitril</text></annotation></passage></document>
<document><id>21725786</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Minimally invasive aspiration was applied within 72 h after onset, along with mannitol or furosemide to lower the intracranial pressure and symptomatic treatment.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="78" length="8"/><text>mannitol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="90" length="10"/><text>furosemide</text></annotation></passage></document>
<document><id>19117965</id><passage><infon key="DDI">No</infon><offset>0</offset><text>It is unknown whether the glycosaminoglycan drug sulodexide interferes with transforming growth factor-beta1--a member of heparin-binding family and a potent regulator of human biology and diseases.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="49" length="10"/><text>sulodexide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="122" length="7"/><text>heparin</text></annotation></passage></document>
<document><id>20120778</id><passage><infon key="DDI">No</infon><offset>0</offset><text>It may be concluded that 40 mg enalapril or 200 mg losartan are not sufficient to reduce proteinuria and blood pressure significantly in type 2 proteinuric diabetics with renal dysfunction although both drugs were well tolerated at high doses.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="31" length="9"/><text>enalapril</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="51" length="8"/><text>losartan</text></annotation></passage></document>
<document><id>22796916</id><passage><infon key="DDI">No</infon><offset>0</offset><text>After having experienced a significant stress on a job the patient ingested huge amount of pregabalin (4,2 r) together with bromazepam (21 mg) and chlorimipramine (125 mg).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="91" length="10"/><text>pregabalin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="124" length="10"/><text>bromazepam</text></annotation></passage></document>
<document><id>23493838</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Bosutinib effectively inhibits wild-type BCR-ABL and most imatinib-resistant BCR-ABL mutations except for V299L and T315I.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="9"/><text>bosutinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="58" length="8"/><text>imatinib</text></annotation></passage></document>
<document><id>22898727</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The purpose of this study was to evaluate the efficacy of lamivudine (LAM) versus telbivudine (LdT) in the treatment of chronic hepatitis B (CHB).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="58" length="10"/><text>lamivudine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="82" length="11"/><text>telbivudine</text></annotation></passage></document>
<document><id>21091127</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Pegfilgrastim prescribed as prophylaxis resulted in lower risk of neutropenia-related and all-cause hospitalizations compared to filgrastim prophylaxis.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="13" length="13"/><text>pegfilgrastim</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="142" length="10"/><text>filgrastim</text></annotation></passage></document>
<document><id>22505603</id><passage><infon key="DDI">No</infon><offset>0</offset><text>It was concluded that all protocols provided adequate analgesia and when used with midazolam-medetomidine-ketamine are effective for routine feline ovariohysterectomy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="83" length="9"/><text>midazolam</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="106" length="8"/><text>ketamine</text></annotation></passage></document>
<document><id>22913325</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Here, we report that systemic or local administration of SB-277011A, a highly selective D3 R antagonist, into the NAc (core and shell) or the CeA, but not the dorsal striatum or basolateral amygdala, significantly inhibits expression of incubation of cocaine craving in rats after 2-30 days of withdrawal from previous cocaine self-administration but had no effect on sucrose-seeking behavior in rats after 10-30 days of withdrawal.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="319" length="7"/><text>cocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="368" length="7"/><text>sucrose</text></annotation></passage></document>
<document><id>21126378</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Compared to IDC, ILC showed a larger tumor size (= T2, 59.8% vs. 38.8%, P = 0.001), a lower histologic grade (HG 1/2, 90.4% vs. 64.4%, P &lt; 0.001), more frequent estrogen receptor positive (90.4% vs. 64.4%, P &lt; 0.001), progesterone receptor positive (71.1% vs. 50.1%, P &lt; 0.001) and HER2 negative (97.5% vs. 74.6%, P &lt; 0.001) status, and lower Ki-67 expression (10.3% ± 10.6% vs. 20.6% ± 19.8%, P &lt; 0.001), as well as being more likely to be of the luminal A subtype (91.4% vs. 51.2%, P &lt; 0.001).</text><annotation id="0"><infon key="type">DrugName</infon><location offset="218" length="12"/><text>progesterone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="448" length="7"/><text>luminal</text></annotation></passage></document>
<document><id>21751893</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Exenatide can reduce glycemic variability compared with glimepiride, providing additional beneficial effects in controlling glucose homeostasis.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="12" length="9"/><text>exenatide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="68" length="11"/><text>glimepiride</text></annotation></passage></document>
<document><id>20164447</id><passage><infon key="DDI">No</infon><offset>0</offset><text>On the seventh postoperative day, the amplitudes of the ERG b-waves were significantly lower in the vehicle group than in the groups pretreated with captopril or candesartan.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="149" length="9"/><text>captopril</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="162" length="11"/><text>candesartan</text></annotation></passage></document>
<document><id>20226526</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Gefitinib (Iressa, ZD1839), a selective epidermal growth factor receptor tyrosine kinase inhibitor, inhibits growth, invasion and colony formation of various cancer cells.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="9"/><text>gefitinib</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="11" length="6"/><text>iressa</text></annotation></passage></document>
<document><id>23324167</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BACKGROUND: Due to the limited data available in literature, the aim of this multi-centre study was to prospectively compare in thalassemia major (TM) patients the efficacy of combined deferiprone (DFP) and deferoxamine (DFO) regimen versus either DFP and DFO in monotherapy by cardiovascular magnetic resonance (CMR) over a follow up of 18 months.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="185" length="11"/><text>deferiprone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="207" length="12"/><text>deferoxamine</text></annotation></passage></document>
<document><id>22205538</id><passage><infon key="DDI">No</infon><offset>0</offset><text>A guanine (G)/adenine (A) common single nucleotide polymorphism at first position of codon 589 in Exo 1 gene determines a glutamic acid (Glu, E) to lysine (Lys, K) (K589E) aminoacidic substitution which may alter cancer risk by influencing the activity of Exo 1 protein.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="2" length="7"/><text>guanine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="14" length="7"/><text>adenine</text></annotation></passage></document>
<document><id>19272368</id><passage><infon key="DDI">No</infon><offset>0</offset><text>RESULTS: It was found that the levels of acylated, desacylated ghrelin, paraoxonase arylesterase, total cholesterol and triglyceride were lower in depressive patients before citalopram treatment than in the control group.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="104" length="11"/><text>cholesterol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="174" length="10"/><text>citalopram</text></annotation></passage></document>
<document><id>20203132</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Specific activities of SOD, CAT, GPX, GR and GST and serum testosterone and progesterone were significantly decreased, while H2O2, LPO and serum FSH was increased in 50-parts per million (ppm) and 200 ppm-treated rats in an age-dependent manner.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="59" length="12"/><text>testosterone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="76" length="12"/><text>progesterone</text></annotation></passage></document>
<document><id>23259390</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Studies of combined therapy with pemetrexed, and bevacizumab beyond progression, are ongoing.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="33" length="10"/><text>pemetrexed</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="49" length="11"/><text>bevacizumab</text></annotation></passage></document>
<document><id>22929843</id><passage><infon key="DDI">No</infon><offset>0</offset><text>24 ml of Bupivacaine 0.5% with injection Dexamethasone 4 mg was used to block the individual four nerves with 6 ml of the local anaesthetic solution per nerve namely ulnar, radial, median and musculocutaneous.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="9" length="11"/><text>bupivacaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="41" length="13"/><text>dexamethasone</text></annotation></passage></document>
<document><id>22005424</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Faecal concentrations of butyrate, histamine, agmatine and spermine were lower (P = 0.05) and faecal pH was higher (P = 0.03) in older dogs than in mature adult dogs, suggesting an alteration in bacterial metabolic activity, or in the rate of intestinal absorption of these compounds.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="46" length="8"/><text>agmatine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="59" length="8"/><text>spermine</text></annotation></passage></document>
<document><id>19035202</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In vitro chemosensitivities of pancreatic carcinoma cells to 5-FU, gemcitabine and oxaliplatin were lower than those of gastrointestinal carcinoma.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="67" length="11"/><text>gemcitabine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="83" length="11"/><text>oxaliplatin</text></annotation></passage></document>
<document><id>22765761</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Relative increases in the levels of lactate, alanine, low-density lipoprotein-very low-density lipoprotein, and unsaturated fatty acids, and decreases in choline, phosphocholine, and glucose were observed after swimming.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="170" length="7"/><text>choline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="163" length="14"/><text>phosphocholine</text></annotation></passage></document>
<document><id>20847545</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Exposure to ethanol during pregnancy increases IGF-I and IGF-II and decreases leptin during early childhood.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="24" length="7"/><text>ethanol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="90" length="6"/><text>leptin</text></annotation></passage></document>
<document><id>21232079</id><passage><infon key="DDI">No</infon><offset>0</offset><text>PURPOSE:  To evaluate the efficacy of treatment of diffuse diabetic macular oedema (DME) with difluprednate ophthalmic emulsion 0.05% (Durezol?) in eyes before vitrectomy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="94" length="13"/><text>difluprednate</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="135" length="7"/><text>durezol</text></annotation></passage></document>
<document><id>21354264</id><passage><infon key="DDI">No</infon><offset>0</offset><text>They have also been shown to reduce alcohol consumption, suppress reward induced by alcohol, cocaine and amphetamine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="93" length="7"/><text>cocaine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="105" length="11"/><text>amphetamine</text></annotation></passage></document>
<document><id>21690280</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Amycolatopsis balhimycina produces the vancomycin-like glycopeptide balhimycin and therefore has to protect itself from the action of the glycopeptide.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="39" length="10"/><text>vancomycin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="68" length="10"/><text>balhimycin</text></annotation></passage></document>
<document><id>22889204</id><passage><infon key="DDI">No</infon><offset>0</offset><text>We showed that vanadium accelerates transfer of the tetracycline resistance gene tet(M) from Photobacterium to Escherichia coli, and found a positive correlation between the concentration of vanadium in natural marine sediment and the rate of oxytetracycline resistance.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="246" length="12"/><text>tetracycline</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="243" length="15"/><text>oxytetracycline</text></annotation></passage></document>
<document><id>21045724</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Carvedilol seems more potent in this regard, whereas nebivolol more effectively prevents the shift to a nondipping BP profile and is better tolerated.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="10"/><text>carvedilol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="53" length="9"/><text>nebivolol</text></annotation></passage></document>
<document><id>20141348</id><passage><infon key="DDI">No</infon><offset>0</offset><text>TAKE HOME MESSAGE: The triple combination therapy of simvastatin/ER niacin/laropiprant may reduce flushing side effects and facilitate a more comprehensive treatment for patients with mixed dyslipidemia.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="53" length="11"/><text>simvastatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="68" length="6"/><text>niacin</text></annotation></passage></document>
<document><id>23153065</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Riboflavin (vitamin B2) is the universal precursor of the coenzymes flavin mononucleotide and flavin adenine dinucleotide--cofactors that are essential for the activity of a wide variety of metabolic enzymes in animals, plants, and microbes.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="10"/><text>riboflavin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="101" length="7"/><text>adenine</text></annotation></passage></document>
<document><id>20562428</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Tobramycin and gentamicin can safely be given by slow push.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="10"/><text>tobramycin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="15" length="10"/><text>gentamicin</text></annotation></passage></document>
<document><id>21865556</id><passage><infon key="DDI">No</infon><offset>0</offset><text>IFNT also suppresses expression of classical IFN-stimulated genes by uterine lumenal epithelium (LE) and superficial glandular (sGE) epithelium but, acting in concert with progesterone, affects expression of a multitude of genes critical to growth and development of the conceptus.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="69" length="7"/><text>uterine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="172" length="12"/><text>progesterone</text></annotation></passage></document>
<document><id>20367203</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Rizatriptan 10 mg has demonstrated, in a head-to-head study, higher response rates and a more rapid onset of action than sumatriptan 100 mg, together with a favorable tolerability profile.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="11"/><text>rizatriptan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="121" length="11"/><text>sumatriptan</text></annotation></passage></document>
<document><id>19154777</id><passage><infon key="DDI">No</infon><offset>0</offset><text>When rats were anesthetized with isoflurane, which increases GABA-mediated inhibition, the salicylate-induced AC amplitude enhancement was abolished, whereas ketamine, which blocks N-methyl-d-aspartate receptors, further increased the salicylate-induced AC amplitude enhancement.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="33" length="10"/><text>isoflurane</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="158" length="8"/><text>ketamine</text></annotation></passage></document>
<document><id>23561361</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Re: monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="21" length="9"/><text>tadalafil</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="34" length="10"/><text>tamsulosin</text></annotation></passage></document>
<document><id>20202011</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSIONS: Our data show that flutamide suppresses the adrenal androgens in comparison with bicalutamide.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="32" length="9"/><text>flutamide</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="94" length="12"/><text>bicalutamide</text></annotation></passage></document>
<document><id>22718191</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Thus, cilastatin has the potential to prevent cisplatin nephrotoxicity without compromising its anticancer efficacy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="6" length="10"/><text>cilastatin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="46" length="9"/><text>cisplatin</text></annotation></passage></document>
<document><id>21920729</id><passage><infon key="DDI">No</infon><offset>0</offset><text>AIM: Non-pegylated liposomal doxorubicin (NPLD) has demonstrated equivalent antitumour activity to conventional doxorubicin and a significantly lower risk of cardiotoxicity when given as a single agent or in combination with cyclophosphamide.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="112" length="11"/><text>doxorubicin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="225" length="16"/><text>cyclophosphamide</text></annotation></passage></document>
<document><id>21789688</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Nine patients had to have dose reductions of fludarabine and doxorubicin, none of whom had grade 3 or 4 toxic effects at the lower dose.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="45" length="11"/><text>fludarabine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="61" length="11"/><text>doxorubicin</text></annotation></passage></document>
<document><id>21440734</id><passage><infon key="DDI">No</infon><offset>0</offset><text>At 3 months, patients were randomized to either lower doses of tacrolimus or sirolimus to examine the effects of maintenance immunosuppression on PBL reemergence.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="63" length="10"/><text>tacrolimus</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="77" length="9"/><text>sirolimus</text></annotation></passage></document>
<document><id>20734230</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Thiamine did not alter the actions of ROS on ER calcium or CCE.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="8"/><text>thiamine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="48" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>21173078</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Losartan did not block the antihypertrophic effects of Ang1-9, or Ang1-7 on vasopressin-stimulated cardiomyocytes.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="0" length="8"/><text>losartan</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="76" length="11"/><text>vasopressin</text></annotation></passage></document>
<document><id>21753888</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: The results of the present study suggest that combined treatment with alendronate and alfacalcidol may be useful to reduce bone turnover and increase the lumbar spine BMD in patients with severe bone loss and osteoporotic fracture.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="82" length="11"/><text>alendronate</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="98" length="12"/><text>alfacalcidol</text></annotation></passage></document>
<document><id>19873644</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Conversely, the bisquaternary hexamethonium, normally a competitive inhibitor, causes depolarization, and the activity of decamethonium is increased following reduction of the disulfide.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="30" length="13"/><text>hexamethonium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="122" length="13"/><text>decamethonium</text></annotation></passage></document>
<document><id>20560730</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: Nebivolol has a significant BP reduction effect in patients with OSA that is similar to valsartan and reduces heart rate to a greater extent which may prove beneficial in selected patients.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="12" length="9"/><text>nebivolol</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="100" length="9"/><text>valsartan</text></annotation></passage></document>
<document><id>22093497</id><passage><infon key="DDI">No</infon><offset>0</offset><text>OBJECTIVE: To evaluate the efficacy of methotrexate treatment for extrauterine pregnancy and define criteria for prediction of success.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="39" length="12"/><text>methotrexate</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="127" length="7"/><text>success</text></annotation></passage></document>
<document><id>22732219</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The amount of free sugar (glucose, fructose and sucrose) was lower in siz1-2 mutants than that in wild-type.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="35" length="8"/><text>fructose</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="48" length="7"/><text>sucrose</text></annotation></passage></document>
<document><id>20044076</id><passage><infon key="DDI">No</infon><offset>0</offset><text>At the post-gavage scan, the EtOH group had lower dorsal hippocampal N-acetylaspartate and total creatine and higher choline-containing compounds than the Con group.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="97" length="8"/><text>creatine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="117" length="7"/><text>choline</text></annotation></passage></document>
<document><id>19187647</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BACKGROUND: It was reported that combination of mycophenolate mofetil (MMF) and enalapril could reduce proteinuria, improve renal function, and down-regulate diabetes-induced macrophage recruitment and expression of monocyte chemotactic protein 1 (MCP-1) and transforming growth factor beta (TGF-beta) in diabetic renal tissue.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="48" length="21"/><text>mycophenolate mofetil</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="80" length="9"/><text>enalapril</text></annotation></passage></document>
<document><id>20840386</id><passage><infon key="DDI">No</infon><offset>0</offset><text>L-659,066 has great potential for clinical use to prevent the cardiovascular effects of dexmedetomidine mediated by peripheral a(2) -adrenoceptors, whereas the effects of verapamil were marginal.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="88" length="15"/><text>dexmedetomidine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="171" length="9"/><text>verapamil</text></annotation></passage></document>
<document><id>22097378</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In this study, the straws of Bt corn and its near-isogenic non-Bt line were added into soil with an application rate of 5% and 7.5% to breed Eisenia fetida, and the total protein content and the activities of acetylcholine esterase (AchE), glutathione peroxidase (GSH-PX), catalase (CAT), and superoxide dismutase (SOD) in E. fetida were determined after 7 and 14 days.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="209" length="13"/><text>acetylcholine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="240" length="11"/><text>glutathione</text></annotation></passage></document>
<document><id>22256576</id><passage><infon key="DDI">No</infon><offset>0</offset><text>BACKGROUND: In this study, we evaluated the efficacy of continuous intravenous infusion of flurbiprofen axetil (FA) combined with tramadol hydrochloride (TH) for postoperative pain control after laparoscopic colectomy.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="91" length="12"/><text>flurbiprofen</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="130" length="8"/><text>tramadol</text></annotation></passage></document>
<document><id>22091283</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The lower blood pressure in the remifentanil TCI with desflurane anesthetic regimens may be a significant advantage.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="32" length="12"/><text>remifentanil</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="54" length="10"/><text>desflurane</text></annotation></passage></document>
<document><id>21541522</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The combinations of radiation therapy and several drugs have been tested, but the efficacy of 5-fluorouracil plus levamisole in rectal cancer is not determined yet.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="96" length="12"/><text>fluorouracil</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="114" length="10"/><text>levamisole</text></annotation></passage></document>
<document><id>19305055</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Taking an appropriate dosage and providing patients with proper instructions on taking the drug concurrently with fatty food are required for effective treatment with artemether-lumefantrine.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="167" length="10"/><text>artemether</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="178" length="12"/><text>lumefantrine</text></annotation></passage></document>
<document><id>22548718</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The 32 pregnancies developed in the follow-up period upon administration of acetylsalicylic acid (ASA) and maintenance dose low molecular weight heparin (LMWH), together with prednisolone in patients with secondary APS, resulted in 23 deliveries and 5 miscarriages; 4 pregnancies are currently in progress.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="145" length="7"/><text>heparin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="175" length="12"/><text>prednisolone</text></annotation></passage></document>
<document><id>21188126</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Interestingly, the activity of cetuximab was restricted to patients with KRAS wildtype tumors, as was seen with panitumumab, another EGFR antibody.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="31" length="9"/><text>cetuximab</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="112" length="11"/><text>panitumumab</text></annotation></passage></document>
<document><id>20509023</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Uric acid stone contained lower amount of total lipids than calcium oxalate and magnesium ammonium phosphate stones.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="60" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="80" length="9"/><text>magnesium</text></annotation></passage></document>
<document><id>23325481</id><passage><infon key="DDI">No</infon><offset>0</offset><text>CONCLUSION: No dosage adjustment is necessary for metformin when coadministered with trospium chloride XR.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="50" length="9"/><text>metformin</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="85" length="8"/><text>trospium</text></annotation></passage></document>
<document><id>21227003</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In the dose-response analysis, the 50% and 95% effective doses were lower for sevoflurane than for propofol in both muscles, although this did not reach statistical significance.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="78" length="11"/><text>sevoflurane</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="99" length="8"/><text>propofol</text></annotation></passage></document>
<document><id>21938493</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Interestingly, throughout the last 60 years, there have been a host of apparently unrelated studies using probenecid in the clinical and basic research arena, including its potential use in the diagnosis and treatment of depression and its use to prevent fura-2 leakage in calcium transient studies.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="106" length="10"/><text>probenecid</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="273" length="7"/><text>calcium</text></annotation></passage></document>
<document><id>21806612</id><passage><infon key="DDI">No</infon><offset>0</offset><text>Therefore, phosphopeptides can increase calcium or iron bioavailability and prevent lipid oxidation in foods.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="40" length="7"/><text>calcium</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="51" length="4"/><text>iron</text></annotation></passage></document>
<document><id>21282452</id><passage><infon key="DDI">No</infon><offset>0</offset><text>In contrast to the routine testing medium, which is of high osmolarity, susceptibility tests using low-osmolarity medium showed that the ?ompK35 mutation resulted in a significant (= 4-fold) increase in the MICs of cefazolin and ceftazidime, whereas a ?ompK36 deletion conferred a significantly (4-fold) lower increase in the MIC of cefazolin.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="229" length="11"/><text>ceftazidime</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="333" length="9"/><text>cefazolin</text></annotation></passage></document>
<document><id>22687573</id><passage><infon key="DDI">No</infon><offset>0</offset><text>The most significant decreases detected (P&lt; 0.001) in both C418/Xa23 and C418-Xa21 were in three amino acids: glycine, tyrosine, and alanine, and four identified metabolites: malic acid, ferulic acid, succinic acid, and glycerol.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="110" length="7"/><text>glycine</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="220" length="8"/><text>glycerol</text></annotation></passage></document>
<document><id>22959189</id><passage><infon key="DDI">No</infon><offset>0</offset><text>An experiment was carried out to study the possible interaction between dexamethasone (DXM) treatment and the efficacy of ivermectin (IVM) treatment in young cattle.</text><annotation id="0"><infon key="type">DrugName</infon><location offset="72" length="13"/><text>dexamethasone</text></annotation><annotation id="1"><infon key="type">DrugName</infon><location offset="122" length="10"/><text>ivermectin</text></annotation></passage></document>
</collection>
